Revascularization Results in Nonagenarian Patients With Critical Lower Limb Ischaemia
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 53
- 主要终点
- Incidence at 30 days of major adverse cardiovascular events (MACE)
研究概览
简要总结
The rise in life expectancy implies an increased number of nonagenarian patients who need evaluation for critical lower limb ischaemia (CLI). The study goal is to evaluate whether revascularization techniques in these patients fulfill a set of security and efficacy criteria generated from surgical results in a validated historical cohort.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 90 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients suffering from Critical Limb Ischemia aged 90 year-old or above
排除标准
- 未提供
结局指标
主要结局
Incidence at 30 days of major adverse cardiovascular events (MACE)
时间窗: 30 days after the procedure
Incidence at 30 days of major adverse cardiovascular events (MACE): stroke, myocardial infarction or death by cardiovascular cause, in percentage.
Incidence at 30 days of major adverse limb events (MALE)
时间窗: 30 days after the procedure
Incidence at 30 days of major adverse limb events (MALE): limb acute ischemia or amputation, in percentage.
Incidence at 30 days of limb major amputations (MA)
时间窗: 30 days after the procedure
Incidence at 30 days of limb major amputations (MA), in percentage.
次要结局
- Limb salvage (LS)(12 months after the procedure)
- Survival(12 months after the procedure)
研究者
Joaquin de Haro, M.D.
Joaquin de Haro, M.D.
Hospital Universitario Getafe